Results 111 to 120 of about 5,636 (198)

Harmine-Based Therapies to Promote Beta Cell Regeneration

open access: yes, 2019
Diabetes is a disease diagnosed by the inability to regulate blood glucose concentration. A primary cause of diabetes is loss of insulin-producing pancreatic cells, or beta cells, which permanently affects insulin production capacity.
Zlatanic, Viktor
core  

Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis. [PDF]

open access: yesMol Med Rep
Chen J   +8 more
europepmc   +1 more source

Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: a factorial dose-escalation study

open access: yes
Ayahuasca, a traditional psychoactive Amazonian brew, usually contains N,N-dimethyltryptamine (DMT) and β-carboline (harmine, harmaline, tetrahydroharmine) monoamine oxidase inhibitors.
Jareño Redondo, Javier   +15 more
core   +1 more source

Human and mouse regenerative macrophages enhance beta cell survival, function, and proliferation. [PDF]

open access: yesIslets
Monajemi M   +7 more
europepmc   +1 more source

ZDWX-25, a dual DYRK1A/GSK3β inhibitor, attenuates tau hyperphosphorylation and neuroinflammation in acute mouse models. [PDF]

open access: yesFront Pharmacol
Wang W   +12 more
europepmc   +1 more source

Harmine Derivatives Alleviate LPS-Induced Acute Lung Injury via Targeting GSK3β. [PDF]

open access: yesInflammation
Ye X   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy